126 related articles for article (PubMed ID: 2561734)
21. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
Mioh H; Chen JK
J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412
[TBL] [Abstract][Full Text] [Related]
22. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
[TBL] [Abstract][Full Text] [Related]
23. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line.
Mulder KM; Ramey MK; Hoosein NM; Levine AE; Hinshaw XH; Brattain DE; Brattain MG
Cancer Res; 1988 Dec; 48(24 Pt 1):7120-5. PubMed ID: 3191488
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of human colon carcinoma.
Brattain MG; Levine AE; Chakrabarty S; Yeoman LC; Willson JK; Long B
Cancer Metastasis Rev; 1984; 3(3):177-91. PubMed ID: 6437669
[TBL] [Abstract][Full Text] [Related]
25. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.
Levine AE; Black B; Brattain MG
J Cell Physiol; 1989 Mar; 138(3):459-66. PubMed ID: 2925796
[TBL] [Abstract][Full Text] [Related]
26. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones.
Grégoire M; Garrigue L; Blottière HM; Denis MG; Meflah K
Invasion Metastasis; 1992; 12(3-4):185-96. PubMed ID: 1338201
[TBL] [Abstract][Full Text] [Related]
27. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis.
Fidler IJ
Cancer Metastasis Rev; 1986; 5(1):29-49. PubMed ID: 2942306
[TBL] [Abstract][Full Text] [Related]
28. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
Prewett M; Rothman M; Waksal H; Feldman M; Bander NH; Hicklin DJ
Clin Cancer Res; 1998 Dec; 4(12):2957-66. PubMed ID: 9865906
[TBL] [Abstract][Full Text] [Related]
29. Unique patterns of brain metastasis produced by different human carcinomas in athymic nude mice.
Schackert G; Price JE; Bucana CD; Fidler IJ
Int J Cancer; 1989 Nov; 44(5):892-7. PubMed ID: 2583868
[TBL] [Abstract][Full Text] [Related]
30. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide.
Xie K; Bielenberg D; Huang S; Xu L; Salas T; Juang SH; Dong Z; Fidler IJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2283-94. PubMed ID: 9815626
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma.
Ananth S; Knebelmann B; Grüning W; Dhanabal M; Walz G; Stillman IE; Sukhatme VP
Cancer Res; 1999 May; 59(9):2210-6. PubMed ID: 10232610
[TBL] [Abstract][Full Text] [Related]
32. Induction of carcinoembryonic antigen and its crossreactive gene products in human colonic adenomas and carcinomas by transforming growth factor-beta.
Chakrabarty S; Mustain S; Willson JK
Mol Biother; 1990 Mar; 2(1):27-31. PubMed ID: 2334536
[TBL] [Abstract][Full Text] [Related]
33. Bovine colostric transforming growth factor-beta-like peptide that induces growth inhibition and changes in morphology of human osteogenic sarcoma cells (MG-63).
Tokuyama H; Tokuyama Y
Cell Biol Int Rep; 1989 Mar; 13(3):251-8. PubMed ID: 2706687
[TBL] [Abstract][Full Text] [Related]
34. Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and -independent mechanisms.
Nishida J; Miyazono K; Ehata S
Oncogene; 2018 Apr; 37(16):2197-2212. PubMed ID: 29391598
[TBL] [Abstract][Full Text] [Related]
35. Differential inhibition of transforming growth factor beta 1 and beta 2 activity by alpha 2-macroglobulin.
Danielpour D; Sporn MB
J Biol Chem; 1990 Apr; 265(12):6973-7. PubMed ID: 1691181
[TBL] [Abstract][Full Text] [Related]
36. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
[TBL] [Abstract][Full Text] [Related]
37. IGFBP-3 mediates TGF beta 1 proliferative response in colon cancer cells.
Kansra S; Ewton DZ; Wang J; Friedman E
Int J Cancer; 2000 Aug; 87(3):373-8. PubMed ID: 10897042
[TBL] [Abstract][Full Text] [Related]
38. Roles of transforming growth factor beta in inhibition of androgen-induced growth of Shionogi carcinoma cells in serum-free medium.
Yamanishi H; Nonomura N; Tanaka A; Yasui T; Nishizawa Y; Matsumoto K; Sato B
Cancer Res; 1990 Oct; 50(19):6179-83. PubMed ID: 2169337
[TBL] [Abstract][Full Text] [Related]
39. Growth modulatory effects of a liver-derived growth inhibitor, transforming growth factor beta 1, and recombinant tumor necrosis factor alpha, in normal and neoplastic cells.
Chapekar MS; Huggett AC; Thorgeirsson SS
Exp Cell Res; 1989 Nov; 185(1):247-57. PubMed ID: 2806409
[TBL] [Abstract][Full Text] [Related]
40. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type.
Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD
J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
